|
Volume 272, Number 49, Issue of December 5, 1997
pp. 30911-30917
The Role of 1 1 Integrin in Wound Contraction
A QUANTITATIVE ANALYSIS OF LIVER MYOFIBROBLASTS IN
VIVO AND IN PRIMARY CULTURE*
(Received for publication, May 13, 1997, and in revised form, September 10, 1997)
Lorraine
Racine-Samson
,
Don C.
Rockey
and
D. Montgomery
Bissell
From the Liver Center Laboratory, San Francisco General Hospital,
and the Department of Medicine, University of California,
San Francisco, California 94110
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
An unresolved question in wound contraction
concerns the identity of integrins mediating the attachment of tissue
myofibroblasts to matrix in the injury site. Previous studies with cell
lines have focussed on 1 1 and 2 1, the principal
collagen-binding integrins, but have yielded conflicting data. We have
examined this issue in wound healing in the liver, isolating the
myofibroblast population (activated stellate cells) and
quantitating expression of the 1 and 2 integrin subunits during
the in vivo injury. Normal stellate cells displayed 1
but no detectable 2. During injury, 1 expression was maintained;
2 became detectable at the mRNA level but at all times was <8%
of 1 mRNA. Contraction of collagen lattices, studied with 24-h
cultured cells and initiated by endothelin 1, was blocked 70% by
anti- 1 and 30% by anti- 2 (both significant, p < 0.05). The inhibition by anti- 2, which was unexpected, was
attributable to culture-induced change in integrin expression; both the
mRNA and protein for 2 increased strikingly within 24 h of
plating stellate cells on a collagen gel. We conclude that 1 1 is
the sole integrin utilized by contracting myofibroblasts in
vivo. Although 2 1 is capable of mediating contraction, its
expression by myofibroblasts occurs largely, if not exclusively, in
response to culture.
INTRODUCTION
Wound repair is a multi-step process in which contraction is an
important element (1). In its initial phase, mesenchymal cells are
drawn to the injury site, where they deposit a collagen-rich extracellular matrix (ECM).1
The ECM undergoes organization, with alignment of collagen fibrils. Myofibroblasts attach via matrix-binding surface receptors, which provide points of traction as cells shorten. The contractile action compacts the ECM lattice, promoting wound closure and restoring tissue
integrity. Although this process is vital to host defense, it has a
negative side. In epithelial tissues, repetitive injury leads to
multiple cycles of wound repair with extensive deposition of ECM.
Contraction in this setting may distort and disrupt tissue structure
with undesirable consequences. For example, strips of cirrhotic liver
are contractile (2), a property that may contribute to the portal
hypertension that accompanies chronic liver disease.
For these reasons the molecular basis of contraction is under study. An
important goal is characterizing the receptors that mediate the binding
of myofibroblasts to ECM, as these are potential targets for
therapeutic modulation of contraction. Given the importance of an
organized collagen matrix to the contraction process, the "classical" collagen-binding receptors, 1 1 and 2 1
integrins, have come under particular scrutiny. Several investigations
have taken advantage of the fact that cell lines with
myofibroblast-like characteristics express one or both of these
integrins (3-7). The conclusions have varied. A persuasive study with
skin fibroblasts found that 2 1 was essential and sufficient for
contraction (7). In contrast, a recent report described a smooth muscle
cell line that expresses 1 1 only and is fully contractile; the
same study found 2 1 is not detectable by immunohistochemistry
during vascular wound healing (4), raising questions about the in
vivo relevance of 2 expression in culture.
The present studies address the role of these integrins in
vivo, in liver undergoing wound repair. Two models of liver injury have been used: total ligation of the bile duct and administration of
dimethylnitrosamine. Both procedures reproducibly induce wound repair
as evidenced by the appearance in the liver of myofibroblasts and
fibrogenesis. The myofibroblast population in liver derives largely
from stellate cells, which are liver pericytes (also known as Ito
cells, fat-storing cells, or lipocytes) (8-10). In injury, stellate
cells undergo a transition to myofibroblasts that is well-documented
and has been termed activation (10). The singular advantage
of the liver model for studies of wound repair is the availability of
methods for preparing mass isolates of stellate cells. By analysis of
isolates at various time points during the evolution of the injury,
direct information on gene expression and function is obtained,
representing a profile of in vivo integrin expression.
Amplification of cells in culture, which routinely results in
phenotypic change (10, 11), is avoided. The isolated cells are suitable
also for direct in vitro assessment of their ECM binding
activity and contractility.
EXPERIMENTAL PROCEDURES
Antibodies
Monoclonal blocking antibodies against rat 1
(clone Ha31/8), 2 (clone Ha1/29), 1 (clone Ha2/11), and murine
1 (clone 3A3) integrin subunits were gifts from V. Koteliansky
(Biogen Inc., Boston, MA) (12-14); clone 3A3 cross-reacts with the rat
protein (4). MA2 polyclonal antibody against the cytoplasmic domain of
murine 2 integrin subunit was a gift from S. A. Santoro (St. Louis, MO) (15, 16). Polyclonal antibodies against the cytoplasmic domains of human integrins 1 and 2 subunits were gifts of G. Tarone (Torino, Italy). Monoclonal antibody against murine v integrin subunit was obtained from Pharmingen (San Diego, CA).
cDNA Probes
The probe for 1 integrin subunit was a
479-base pair cDNA (nucleotides 1871-2350) subcloned into pGEM4Z
(Promega, Madison, WI) from a full-length cDNA provided by M. J. Ignatius (Berkeley, CA) (17). The probe for the 2 integrin
subunit was an 843-base pair cDNA (nucleotides 1456-2299) subclone
in pBluescript II SK- kindly provided by S. A. Santoro (St. Louis,
MO) (15).
Animal Models of Wound Repair
Hepatic injury was induced in
male Sprague-Dawley rats (500-600 g) by ligation of the biliary duct.
Bile duct ligation is well characterized with respect to the time
course and extent of fibrogenesis (18, 19). Sham-operated animals
underwent laparotomy and bile duct manipulation without ligation.
Animals were maintained postoperatively on food and water ad
libitum. In some studies, hepatic fibrosis was induced by
intraperitoneal injection of dimethylnitrosamine in a dose of 1 µl
(diluted 1:100 in 0.15 M NaCl)/100 g body weight given on
the first 3 days of each week (20).
Stellate Cell Isolation and Culture
Stellate cells were
isolated as described (21) by liver perfusion with Pronase (Boehringer
Mannheim) and collagenase (Crescent Serva, Hauppause, NY) followed by
ultracentrifugation on a discontinuous gradient of Accudenz® (8.2 and
15.6% w/v) (Accurate Chemicals, Westbury, NY). The top interface
contained stellate cells, which were collected and washed twice in
culture medium to remove debris. Stellate cells were identified by
their intrinsic vitamin A autofluorescence (22) and by staining for the
intermediate filament, desmin (9). Their purity was >95%. They were
used fresh or plated in a modified medium 199 (23) containing 20%
serum (10% horse, 10% calf; Life Technologies, Inc.).
RNase Protection Assay
Total RNA was extracted from
stellate cells using Tri Reagent® (Molecular Research Center Inc.,
Cincinnati, OH) (24). Sample quality was assessed by
agarose/formaldehyde gel electrophoresis. Radiolabeled antisense RNA
probes were synthetized with the appropriate RNA polymerase (Promega)
in the presence of [ -32P]CTP (>800 Ci/mmol; Amersham
Corp.). Hybridization was performed in solution as described previously
using equivalent amounts of RNA as determined by
A260 readings of the extracts (21). Samples for
a given experiment were run as a group, using the same preparation of
probe(s) and gel analysis. Unhybridized RNA was digested with ribonuclease T2 (19). Intact hybrids were precipitated, denatured by
boiling for 3 min in electrophoresis buffer, and separated by
electrophoresis in a 5% polyacrylamide/urea gel. After drying, gels
were applied to X-OMAT AR-5 film (Eastman Kodak, Rochester, NY).
Scanning densitometry (Hoefer Scientific Instruments, San Francisco,
CA) was used to quantitate the autoradiographic signals. RNA samples
were also hybridized with a cDNA encoding 585 base pairs of the
ribosomal protein S14 (25) as an internal control for the amount of
mRNA present in an individual assay. S14 mRNA varies minimally
after bile duct ligation (21). Densitometric data were normalized to
S14 expression.
Flow Cytometry
Isolated cells were washed with PBS
containing Ca2+ and Mg2+, and 200,000-500,000
cells were incubated in a blocking solution consisting of 10% goat
serum in PBS for 15 min at room temperature. The primary antibody
(clone Ha31/8 for 1, clone Ha1/29 for 2, and clone Ha2/11 for
1) was added to the cell sample and incubated for 25 min on ice.
After washing with PBS, the cells were resuspended in
phycoerythrin-conjugated anti-hamster IgG diluted in PBS (10 µg/106 cells) (Caltag, South San Francisco, CA),
incubated for 20 min on ice in the dark, and then washed. The cells
were analyzed for fluorescence on a FACStarPLUS Flow Cytometer (Becton
Dickinson, San Jose, CA). For control samples, the primary antibody was
replaced by non-immune IgG.
Immunohistochemistry on Liver Sections
The liver was
perfused under low pressure in situ with PBS via the portal
vein until free of blood and then removed and cut into small pieces,
which were snap-frozen in isopentane prechilled in liquid nitrogen and
stored at 80 °C. Immunohistology was performed on 8-µm thick
cryostat sections fixed for 10 min in 20 °C acetone (15, 16).
Sections were incubated 15-30 min in a blocking solution containing
1% fish gelatin (Sigma) in PBS and then incubated with either 3A3
anti- 1 monoclonal antibody (1:500 dilution in blocking solution)
(14) or with MA2 anti- 2 polyclonal antibody (1:200 dilution) (15,
16). A biotinylated sheep anti-mouse IgG (1:200) (Amersham Corp.) or a
biotinylated goat anti-rabbit IgG (1:200) (Vector Laboratories,
Burlingame, CA) was added. After further washes, the sections were
exposed to streptavidin-linked Texas Red (Amersham Corp.) (1:1,000) for
30 min, washed with PBS, and mounted in glycerol for fluorescence
microscopy (Dako Corp., Carpinteria, CA). For negative controls, the
primary antibody was omitted. Results were recorded with a Nikon
Microphot-FX fluorescence microscope and Ilford HP5-plus (ASA 400)
film.
Adhesion Assay
Cell attachment to collagen was performed as
described (26). Briefly, untreated polystyrene 96-well flat-bottom
microtiter plates (Lindro®/Titertek®, Flow Laboratories, McLean, VA)
were coated with collagen type I or IV (10 µg/ml in PBS) (Sigma) or with 1% bovine serum albumin (Sigma) in PBS. Plates were washed with
PBS and then blocked with 1% bovine serum albumin for 1 h. Cells
were plated at a density of 100,000 cells/well in 200 µl of
serum-free medium. For blocking experiments, they were preincubated with antibodies for 15 min at 4 °C before plating. After a 2-h incubation at 37 °C in a humidified 5% CO2 incubator,
non-adherent cells were removed by three washes with PBS. The attached
cells were fixed and stained with a solution containing 3%
formaldehyde, 10% methanol, and 0.5% crystal violet for 1 h.
After washing with PBS to eliminate excess dye, the wells were drained,
and the absorbance at 595 nm was measured in a microplate reader
(Bio-Rad). Values were corrected for background defined as adhesion to
bovine serum albumin alone. Each assay was performed in triplicate.
Collagen Gel Contraction Assay
Contraction of stellate
cells on collagen lattices was examined in 24-well flat-bottom tissue
culture plates (Corning Glass Works, Corning, NY) as described
previously (27). Briefly, culture vessels were preincubated with PBS
containing 1% bovine serum albumin (Sigma) (500 µl per well) for at
least 1 h at 37 °C and then washed twice with PBS and air
dried. The gel mixture consisted of 8 parts Vitrogen (Celltrix Corp.,
Santa Clara, CA), 1 part (10 ×) minimal essential medium (Life
Technologies, Inc.), and 1 part 0.2 M HEPES, pH 9.0, which
resulted in a final collagen concentration of 2.4 mg/ml. It was
prepared at 4 °C, added to the culture vessel, and incubated for
1 h at 37 °C to allow gelation. Stellate cells isolated from
animals 6 days after bile duct ligation were plated on top of the gels.
After cell attachment for 24 h, serum-free conditions were
introduced and endothelin-1 (10 8 M, Peninsula
Laboratories, Belmont, CA) was added to elicit contraction (27).
Contraction was monitored as the change in lattice area over time. For
integrin-blocking experiments, the appropriate antibodies (clones
Ha31/8 for 1, Ha1/29 for 2 and Ha2/11 for 1) were added at
plating. The antibody concentration was one that produced 95-100% of
maximal inhibition, as determined in preliminary experiments. For
anti- 1, this was 217 µg/ml; for anti- 2 it was 223 µg/ml, and
for anti- 1 it was 235 µg/ml (all as purified IgG).
Metabolic Labeling and Immunoprecipitation
Stellate cells
were metabolically labeled with [35S]methionine (5 mCi/100-mm plate; ICN, Irvine, CA) overnight in medium without methionine and cysteine. Cellular proteins were solubilized in immunoprecipitation buffer (100 mM Tris/HCl pH 7.4, 150 mM NaCl, 1 mM CaCl2, 0.1% SDS, 1%
Triton X-100, 0.1% Nodinet P-40, 2 mM phenylmethylsulfonyl
fluoride, 20 µg of aprotinin, 20 µg of leupeptin) for 30 min at
4 °C. The cell lysate was centrifuged 10 min at 10,000 × g, and the supernatant was precleared by incubation with protein A-Sepharose CL-4B beads (1:1, v/v, slurry in
immunoprecipitation buffer; Pharmacia Biotech Inc.) for 45 min at
4 °C. Incubation with appropriate monoclonal antibody (clone Ha31/8
for 1, clone Ha1/29 for 2, and clone Ha2/11 for 1) was carried
out overnight at 4 °C. Rabbit anti-hamster IgG (Pierce) was added
1 h before the end of the incubation, followed by addition of
protein A-Sepharose beads. After a 45-min incubation, the beads with
attached immune complexes were washed five times with
immunoprecipitation buffer and then eluted by boiling for 5 min in
2 × Laemmli loading buffer and resolved in an 8%
SDS-polyacrylamide gel. Dried gels were exposed to X-OMAT AR-5 film
(Kodak).
Confocal Microscopy
For studies of cellular localization of
1 and 2, double labeling experiments were performed on stellate
cells after 3 days in primary culture. Cells were fixed with 1.5%
paraformaldehyde, 0.1% Triton X-100 for 10 min and then immunostained
as described above (see "Immunohistochemistry on Liver Sections").
For evaluating co-localization of 1 or 2 and the actin
cytoskeleton, double labeling using anti-talin antibody (1:100)
(Amersham Corp.) was performed. Staining was analyzed with a confocal
microscope (Meridian ACAS 570, Ohemos, MI). Generated images were
corrected for compensation and threshold.
Statistical Analysis
Values are expressed as mean ± S.E. Statistics were performed with one-way analysis of variance with
multiple comparisons. Statistical significance was assigned at
probability value less than 0.05.
RESULTS
Expression of 1 and 2 Integrin mRNA by Stellate Cells in
Vivo
The expression of 1 and 2 mRNA was examined in
freshly isolated stellate cells and at various time points after bile
duct ligation or dimethylnitrosamine treatment. In stellate cells from normal liver, 1 mRNA was readily detected (Fig.
1, A and B), and
after bile duct ligation, it remained essentially constant over the
6-day period of observation (Fig. 1, A and C). In
contrast, 2 mRNA was undetectable in normal stellate cells (Fig.
1, A and B). Although measurable after bile duct
ligation (Fig. 1, A and C), at all time points it
was less than 8% of 1 mRNA. To test whether these findings were
peculiar to bile duct ligation, which causes periportal injury (28), we
carried out a similar study in rats treated for 1 week with
dimethylnitrosamine. This chemical causes midzonal and pericentral
necrosis (29). The profiles of 1 and 2 expression were entirely
similar (Fig. 1, B and C).
Fig. 1.
In vivo expression of 1 and 2
mRNA by hepatic stellate cells isolated from normal or injured
livers. Hepatic stellate cells were isolated from normal livers or
at different time points after bile duct ligation (BDL, 12 h, 48 h, and 6 (d) days) (A) or after dimethylnitrosamine treatment (1 (w) week
(DMN)) (B), with three animals in each group.
Total RNA was extracted and analyzed by RNase protection assay with
specific probes for the 1 and 2 integrin subunits and for the
ribosomal protein S14. The same RNA extract was used for all probes at
individual time points. A and B, autoradiograms;
arrows indicate specific bands. C, densitometry
quantification of the autoradiogram presented in A and
B showing the relative expression of 1 and 2 mRNA
after correction for S14. Mean ± S.E. for each group
(*p < 0.05 compared with normal). , 1 mRNA;
, 2 mRNA.
[View Larger Version of this Image (27K GIF file)]
Surface Expression of 1, 2, and 1 by Stellate
Cells
Expression at the protein level was assessed with specific
antibodies to 1, 2, and 1 subunits on stellate cells freshly isolated as above. Bound antibody was quantitated by flow cytometry. To
ensure that the integrin subunits of interest were not altered by the
proteases used in cell isolation, we carried out control studies with
WKY cells, a smooth muscle line that is known to express both 1 1
and 2 1 (4). Prior to analysis, WKY cells were exposed to Pronase
and collagenase as for isolation of stellate cells and then washed and
analyzed. All three subunits 1, 2, and 1 were detected (Fig.
2A). In normal stellate cells
(Fig. 2B), 1 and 1 were present but not 2. At
12 h (Fig. 2C) and 6 days (Fig. 2D) after
induction of injury, the findings were essentially the same: 2 was
not detectable despite the observed, albeit small, increase in 2
mRNA at these time points (Fig. 1).
Fig. 2.
Surface expression of 1, 2, and 1
integrin subunits by hepatic stellate cells in vivo.
WKY cells, which express both 1 1 and 2 1, were exposed to
Pronase and collagenase as for isolation of stellate cells and
processed for flow cytometry after incubation with specific monoclonal
antibodies to the extracellular domain of 1, 2, or 1 integrin.
All three subunits were detected (A). Hepatic stellate cells
were isolated from normal liver (B), at 12 h
(C), or 6 days (D) after bile duct ligation
(BDL). At all time points, only 1 and 1 were
detected.
[View Larger Version of this Image (39K GIF file)]
Immunofluorescence Detection of 1 and 2 in Liver Tissue
during Injury
In immunohistology of normal liver, 1 appeared
as a sharp linear stain along the sinusoids consistent with its
localization to stellate or endothelial cells. At 6 days after bile
duct ligation, staining was unchanged. In neither setting was 2
detectable, in agreement with the fluorescence-activated cell sorter
analysis. The reactivity of the 2 antibody in immunohistology was
verified by positive staining of rat footpad skin (30) (data not
shown).
Stellate Cell Binding to Collagen I and IV
Stellate cells
were isolated 6 days after bile duct ligation, and their adhesion to
collagen was tested. Antibody to 1 integrin reduced adhesion to
collagen type I by 90% and to collagen type IV by 95% (Fig.
3). Antibody to 2 had no effect, and
the combination of anti- 1 and anti- 2 had effects similar to those
of anti- 1 alone. Anti- 1 inhibited 55% of the binding to collagen
type I and 80% of the binding to collagen type IV. Although the effect of anti- 1 was on average less than that of anti- 1, the difference was not significant. Anti- v had no effect on binding to either type
of collagen. From these results, and studies at both the mRNA and
the protein levels, we conclude that expression of 2 integrin is
negligible both in normal liver and in the setting of wound
healing.
Fig. 3.
Effect of blocking antibodies to 1, 2,
and 1 integrin subunits on the binding of stellate cells to
collagens I or IV. 96-Well plates were coated with 10 µg/ml
collagen I ( ) or IV ( ). Freshly isolated hepatic stellate cells
were treated or not with the indicated antibodies for 15 min prior to
plating. Coated wells received 100,000 cells. After incubation for
2 h, unattached cells were removed with washes. Bound cells were
stained with crystal violet, and the absorbance was measured at 595 nm.
All values have been corrected for background, estimated as cells adhering to wells coated with bovine serum albumin only. The effect of
antibody is depicted as a percentage of the adhesion observed in the
absence of antibody and represents mean ± S.E. of triplicate wells. At least three independent experiments were performed, of which
a representative one is shown (*p < 0.05 versus adhesion in the absence of antibody).
[View Larger Version of this Image (16K GIF file)]
Role of 1 1 and 2 1 Integrins in Stellate Cell
Contraction
For studies of contraction, stellate cells were
isolated 6 days after bile duct ligation at which time they exhibit
myofibroblast characteristics, attaching rapidly to collagen gels.
Contraction was elicited by endothelin 1 (27, 31, 32), and the decrease in lattice area was monitored in the presence or absence of blocking antibodies to 1, 2, or 1 integrin subunits. Base-line
contraction (indicated as 100% contraction) was established in plates
treated with non-immune IgG and exposed to endothelin 1 (Fig.
4); the gel area was 40-50% that of
non-contracted controls. Anti- 1 blocked contraction significantly.
Unexpectedly, the effect of anti- 2 also was significant although
less than that of anti- 1. Given together, anti- 1 and anti- 2
were additive, completely inhibiting contraction, and anti- 1 was
similarly effective. Antibody to v, which does not bind collagen,
had no effect. When the morphology of cultures on collagen gels was
examined, the effect of an individual antibody on cell processes
correlated closely with its effect on contraction. Processes were
numerous in control cultures or in cultures exposed to anti- v (Fig.
5, a and f). By
contrast, in cultures exposed to anti- 1 or anti- 2 (Fig. 5,
b and c), processes were reduced, and they
were virtually eliminated in cultures containing both anti- 1 and
anti- 2 or anti- 1 (Fig. 5, d and e). None of the antibodies altered cell attachment to the gel.
Fig. 4.
Effect of blocking antibodies to 1, 2,
and 1 integrin subunits on contraction of collagen gels by hepatic
stellate cells. Hepatic stellate cells isolated from livers 6 days
after bile duct ligation were plated on top of collagen I gels in the
absence or presence of specific monoclonal antibodies as indicated.
After 24 h, contraction was elicited by the addition of endothelin
1, and the change in lattice area was monitored; over 24 h
endothelin reduced the diameter of the gel to 40-50% of parallel
control cultures without the agonist. Contraction assays were done in triplicate, and at least three independent experiments were performed for each condition. A representative result is shown. The effect of
blocking antibody is recorded as percent of maximal contraction ± S.E. (*p < 0.05 versus control with
endothelin 1).
[View Larger Version of this Image (12K GIF file)]
Fig. 5.
Effect of blocking antibody to 1, 2, or
1 integrin subunits on stellate cell morphology. Hepatic
stellate cells isolated from livers 6 days after bile duct ligation
were plated on top of collagen I gels in the absence or presence of
specific monoclonal antibodies. After 24 h, the morphology of
living cells was examined by phase-contrast microscopy. a,
no antibody; b, anti- 1; c, anti- 2;
d, anti- 1 + anti- 2; e, anti- 1;
f, anti- v. In the control and in cultures treated with
anti- v, numerous cell processes are present (arrows);
these are reduced in the presence of either anti- 1 or anti- 2 and
nearly abolished by the combination of anti- 1 and anti- 2 or by
anti- 1.
[View Larger Version of this Image (138K GIF file)]
Regulation of 2 1 Expression in Stellate Cells Cultured on
Collagen Gels
A salient difference between these and the
preceding experiments is the fact that the flow cytometry and
collagen-binding studies were conducted with fresh isolates, whereas
the contraction studies required a minimum period in culture (about
24 h) for attachment of the cells to the gel. Because phenotypic
adaptation to culture is known to occur within this time frame (10,
11), we evaluated 2 integrin mRNA expression early after cell
plating. Cells from 6-day bile duct ligated liver were isolated and
placed on collagen gels, and 1 and 2 mRNA were quantitated.
As shown (Table I), 2 mRNA
increased strikingly after just 24 h of culture, and synthesis of
its protein was readily detected by immunoprecipitation after metabolic
labeling. By contrast, 1 expression did not change either at the
mRNA or protein level during 24 h of culture on collagen gels
(Fig. 6). The rapid up-regulation of
2 1 in culture appears to explain its participation in
contraction.
Fig. 6.
Synthesis of 1 1 and 2 1 integrins
by hepatic stellate cells in culture. Hepatic stellate cells in
culture were labeled overnight with [35S]methionine,
lysed as described under "Experimental Procedures" and
immunoprecipitated with monoclonal antibody to 1, 2, or 1
integrins. Immunoprecipitates were resolved by SDS-polyacrylamide gel
electrophoresis and autoradiography. Controls consisted of extracts
processed in parallel with nonspecific antibody.
[View Larger Version of this Image (38K GIF file)]
Distribution of the 1 or 2 Integrin Subunits in Cultured
Stellate Cells and Their Co-localization with the Actin
Cytoskeleton
Double labeling experiments on 3-day cultured
stellate cells revealed a striking difference in the distribution of
1 and 2 integrins (Fig. 7). 1
was present on processes and at the periphery of cells to a much
greater extent than was 2; the latter was concentrated over and
around the nucleus, suggestive of a largely cytoplasmic localization.
Double labeling with anti- 1 and anti-talin showed widespread
co-localization of these proteins. By contrast, the association of 2
and talin was most evident in the cell body. Although not absent in
processes, it was clearly much less than that of 1 and talin. The
data confirm the up-regulation of the 2 integrin subunit but suggest
that the actin cytoskeleton in these early cultures forms peripheral
complexes predominantly with 1 1. The limited localization to
peripheral processes provides a basis for the inhibitory effect, which
is modest but significant, of anti- 2 antibody on the contraction of
stellate cells in culture.
Fig. 7.
Distribution and co-localization of 1 1,
2 1, and talin in early primary cultured stellate cells.
Hepatic stellate cells were cultured for 3 days and immunostained as
described under "Experimental Procedures." Staining was examined
with a confocal microscope (Meridian ACAS 570). Images have been
corrected for compensation and threshold. No smoothing has been
performed. First row, double labeling for 2
(left), 1 (middle), and overlay of the images
(right); co-localization of the two antigens, indicated by
yellow in the overlay image, is limited to the cell body
(arrowhead indicates cell process). Second row,
double labeling for talin (left), 1 (middle),
and overlay of the images (right); co-localization, indicated by yellow in the overlay, is extensive and
includes cell processes (arrowhead). Third row,
double labeling of 2 (left), talin (middle),
and overlay of the two (right); co-localization, indicated
by yellow in the overlay image, is limited and similar to
that of 1 and 2 (top row, right). Top row
and third row: color scale, 0-1200; second row:
full color scale.
[View Larger Version of this Image (60K GIF file)]
DISCUSSION
From studies with individual cell lines, it is clear that both
1 1 and 2 1 may exist on the same cell type and that either or both can provide the anchorage needed for contraction (3-7). On the
other hand, expression of the respective integrins in the mature
organism in vivo appears to be restricted by cell type with
little overlap between the two. The separation appears to be maintained
even in mutant mice lacking 1, in which there is no evidence of a
compensatory increase in 2 expression (33). 1 is expressed on
smooth muscle, microvascular endothelium, glomerular mesangium, mammary
myoepithelial cells, and chondrocytes (33). 2 appears on
fibroblasts, but its predominant distribution is to epithelium,
particularly at sites of proliferation (15, 30). In normal human liver,
it is reportedly on the biliary epithelium, although 1 is present on
hepatocytes and sinusoidal lining cells (34, 35). In the present study,
1 mRNA was found on hepatic stellate cells, whereas 2 was not
detectable even with a sensitive RNase protection assay. After injury,
2 mRNA was detectable although its protein was not, even on the
biliary epithelium. The discrepancy with the 2 data from human liver
may be species-related or reflect a difference in the relative affinity
of the anti-human and anti-murine antibodies.
To ensure that the finding of 2 mRNA was not peculiar to the
biliary ligation model, we performed a similar evaluation of injury
induced by the toxin dimethylnitrosamine, with essentially identical
results. Although the data confirm that liver myofibroblasts may
co-express these integrins (36), the marked predominance of 1 1
indicates that, of the two, it is functionally the most important. This
conclusion is clearly supported by the binding studies, which indicate
that essentially all stellate cell binding to collagen I or IV is
mediated by 1 1 (Fig. 4). The data differ from those of Schiro and
colleagues (7), who evaluated the contractile function of a human
fibroblast cell line and of transfected rhabdomyosarcoma cells,
concluding that only 2 is important. Although the cells reportedly
expressed both 1 and 2 (7), the relative level of these integrins
was not assessed nor was the binding activity of 1 examined. It is
known that a cell line expressing 1 only is capable of contracting a
collagen lattice (4). Thus, it appears that both integrins can subserve
contraction and that the predominance of one or the other in a specific
cell type or physiological circumstance will reflect its relative
expression on the cell surface, apart from considerations of receptor
activation and signaling pathways. Our data indicate that in
vivo the expression of 1 on myofibroblasts far exceeds that of
2.
The role of 1 and 2 integrins in contraction of collagen gels by
activated stellate cells was examined with direct experiments in
vitro, in which cells were plated with or without the appropriate monoclonal blocking antibody. Neither anti- 1 nor anti- 2 (or both
together) reduced cell attachment to the gels, indicating the presence
of other receptor(s). The principal fibronectin receptor, 5 1, is
well expressed by stellate
cells,2 and activated
stellate cells produce significant fibronectin (21), which may add to a
collagenous substratum through its well characterized collagen-binding
domain (37, 38), thus providing a ligand for 5 1. By a similar
mechanism involving other secreted ECM proteins, a variety of receptors
(integrins and others) could substitute for 1 1, mediating the
attachment of cells to collagen gels.
Although not altering attachment, the antibodies to 1 and 2
nonetheless had well-defined effects on morphology, causing retraction
of cell processes. Qualitatively, such effects closely paralleled the
ability of these same antibodies to inhibit contraction. The
morphological change suggests that both integrins occupy the periphery
and cell processes, as would be expected for attachments that provide
traction. Confocal microscopy confirms that this is the case for 1.
The localization of 2 differed in being more central than
peripheral, although the limited expression on cell processes still may
be sufficient to account for the small but significant effect of
anti- 2 on stellate cell contraction. If the change in 2
expression is persistent, as seems likely, the data provide an
explanation for the fact that 2 integrin commonly is present on
smooth muscle cell lines despite its absence on this cell type in
vivo (15, 30). This has implications not only for the use of
myofibroblast lines in modeling contraction but also for primary
culture. Several studies point to the fact that normal stellate cells
respond to culture with a program of gene expression that mimics
activation in vivo (10). The up-regulation of 2 1 in
early primary cells, while demonstrating the latent capacity for
expression of this integrin, indicates that the culture model deviates
significantly from in vivo reality, highlighting the
necessity for routinely validating with intact tissue the findings from
culture models.
The relatively constant expression of 1 1 in normal liver and
during wound healing is at variance with data from other tissues in
which this integrin increases with injury and fluctuates during development, as judged by immunohistology (39, 40). For example, it is
undetectable in the normal rat carotid but clearly present in the
neointima after balloon injury (33), suggesting that its level and
timing may be critical to contraction. In this respect, the injury
response of epithelia may differ from that of the vasculature.
The findings suggest that in liver the level of 1 expression does
not govern the contractile response. If not 1, then what? The
principal contractile agonists for activated stellate cells are
endothelins 1 and 3. Interestingly, expression of their receptors is
prominent on normal stellate cells and, like 1 integrin, unaffected by injury (41). Expression of endothelin 1 by stellate cells, however,
is up-regulated in injury (41, 42). If regulation of contraction by
endothelin is autocrine, then this is significant. Another potentially
regulatory factor is the ECM. Although collagen IV is a ligand for
1 1 and is found normally in the subendothelial space, contraction
may require organized fibrillar collagens, which are sparse in normal
liver. Collagen I is confined largely to vascular branch points where
it may serve as a substratum for vasoregulatory stellate cells (43).
Similarly, contraction in hepatic wound healing may require deposition
of the appropriate substratum in the form of fibrillar collagen (types
I, III, V, and VI) at the injury site. A final variable is the rate at
which stellate cells in the injured liver acquire the necessary
contractile apparatus, which must be synthesized de novo;
this process is mirrored by expression of smooth muscle -actin (8,
9, 11), which increases in parallel with contractility (44).
In summary, contraction of hepatic myofibroblasts in wound healing
utilizes the 1 1 integrin. We find no evidence for a role of
2 1. Because 1 1 is expressed quasi-constitutively,
contractility may depend primarily on formation of a fibrillar ECM at
the injury site, coupled with cellular expression of contractile
proteins and local (autocrine) elaboration of the appropriate agonist
in the form of endothelins 1 and 3. Given that these events are
co-temporal, the possibility exists that they are coordinated by
signaling via 1 1. This is a topic for further studies.
FOOTNOTES
*
This work was supported by the French Association for the
Study of Liver, the French Association for Research on Cancer, the American Liver Foundation (L. R.-S.), and by Grants DK 31198, DK
26743, DK 50574, and DK 02124 from the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Gastrointestinal Unit,
Box 0538, University of California, San Francisco, CA. Tel.:
415-476-5072; Fax: 415-476-0659; E-mail: dmbiss{at}itsa.ucsf.edu.
1
The abbreviations used are: ECM, extracellular
matrix; PBS, phosphate-buffered saline.
2
S. S. Wang and D. M. Bissell,
unpublished observations.
ACKNOWLEDGEMENTS
We thank Victor Koteliansky, Philip Gotwals,
and Biogen Inc. (Boston, MA) for antibodies to 1, 2, and 1 and
for helpful discussions. We thank Samuel Santoro for generously
providing cDNA and antibody to 2 and advice on its use in
immunohistochemistry, and we thank Guido Tarone (Torino, Italy) for
antibody to 1 and 2. Bill Hyun provided valuable assistance with
confocal microscopy through the Microscopy Core Facility of the UCSF
Liver Core Center. L. R.-S. thanks Shao-Shean Wang for precious time
spent in teaching techniques and David Tyler for stellate cell
isolations.
REFERENCES
-
Skalli, O., and Gabbiani, G.
(1988)
in
The Molecular and Cellular Biology of Wound Repair (Clark, R. A. F., and Henson, P. M., eds), pp. 373-402, Plenum Publishing Corp., New York
-
Irle, C., Kocher, O., and Gabbiani, G.
(1980)
J. Submicrosc. Cytol.
12,
209-217
-
Carver, W., Molano, L., Reaves, T. A., Borg, T. K., and Terracio, L.
(1995)
J. Cell. Physiol.
165,
425-437
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gotwals, P. J., Chi-Rosso, G., Lindner, V., Yang, J., Ling, L., Fawell, S. E., and Koteliansky, V. E.
(1996)
J. Clin. Invest.
97,
2469-2477
[Medline]
[Order article via Infotrieve]
-
Klein, C. E., Dressel, D., Steinmayer, T., Mauch, C., Eckes, B., Krieg, T., Bankert, R. B., and Weber, L.
(1991)
J. Cell Biol.
115,
1427-1436
[Abstract/Free Full Text]
-
Lee, R. T., Berditchevski, F., Cheng, G. C., and Hemler, M. E.
(1995)
Circ. Res.
76,
209-214
[Abstract/Free Full Text]
-
Schiro, J. A., Chan, B. M. C., Roswit, W. T., Kassner, P. D., Pentland, A. P., Hemler, M. E., Eisen, A. Z., and Kupper, T. S.
(1991)
Cell
67,
403-410
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ballardini, G., Fallini, M., Biagini, G., Bianchi, F. B., and Pisi, E.
(1988)
Virchows Arch. B Cell Pathol. Incl. Mol. Pathol.
56,
45-49
[Medline]
[Order article via Infotrieve]
-
Rockey, D. C., Boyles, J. K., Gabbiani, G., and Friedman, S.
(1992)
J. Submicrosc. Cytol. Pathol.
24,
193-203
[Medline]
[Order article via Infotrieve]
-
Friedman, S. L.
(1993)
N. Engl. J. Med.
328,
1828-1835
[Free Full Text]
-
Bissell, D. M., and Guzelian, P. S.
(1980)
Ann. N. Y. Acad. Sci.
349,
85-97
[Medline]
[Order article via Infotrieve]
-
Mendrick, D. L., and Kelly, D. M.
(1993)
Lab. Invest.
69,
690-702
[Medline]
[Order article via Infotrieve]
-
Mendrick, D. L., Kelly, D. M., DuMont, S. S., and Sandstrom, D. J.
(1995)
Lab. Invest.
72,
367-375
[Medline]
[Order article via Infotrieve]
-
Turner, D. C., Flier, L. A., and Carbonetto, S.
(1989)
J. Neurosci.
9,
3287-3296
[Abstract]
-
Wu, J. E., and Santoro, S. A.
(1994)
Dev. Dyn.
199,
292-314
[Medline]
[Order article via Infotrieve]
-
Wu, J. E., and Santoro, S. A.
(1996)
Dev. Dyn.
206,
169-181
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ignatius, M. J., Large, T. H., Houde, M., Tawil, J. W., Barton, A., Esch, F., Carbonetto, S., and Reichardt, L. F.
(1990)
J. Cell Biol.
111,
709-720
[Abstract/Free Full Text]
-
Bienkowski, R. S., Cowan, M. J., McDonald, J. A., and Crystal, R. G.
(1978)
J. Biol. Chem.
253,
4356-4363
[Free Full Text]
-
Maher, J. J., and McGuire, R. F.
(1990)
J. Clin. Invest.
86,
1641-1648
-
Ala-Kokko, L., Pihlajaniemi, T., Myers, J. C., Kivirikko, K. I., and Savolainen, E.-R.
(1987)
Biochem. J.
244,
75-79
[Medline]
[Order article via Infotrieve]
-
Jarnagin, W. R., Rockey, D. C., Koteliansky, V. E., Wang, S.-S., and Bissell, D. M.
(1994)
J. Cell Biol.
127,
2037-2048
[Abstract/Free Full Text]
-
Friedman, S. L., and Roll, F. J.
(1987)
Anal. Biochem.
161,
1233-1247
-
Irving, M. G., Roll, F. J., Huang, S., and Bissell, D. M.
(1984)
Gastroenterology
87,
1233-1247
[Medline]
[Order article via Infotrieve]
-
Chomczynski, P.
(1993)
BioTechniques
15,
532-537
[Medline]
[Order article via Infotrieve]
-
Rhoads, D. D., Dixit, A., and Roufa, D. J.
(1986)
Mol. Cell. Biol.
6,
2774-2783
[Abstract/Free Full Text]
-
Weinacker, A., Chen, A., Agrez, M., Cone, R. I., Nishimura, S., Wayner, E., Pytela, R., and Sheppard, D.
(1994)
J. Biol. Chem.
269,
6940-6948
[Abstract/Free Full Text]
-
Rockey, D. C., Housset, C. N., and Friedman, S. L.
(1993)
J. Clin. Invest.
92,
1795-1804
-
Kountouras, J., Billing, B. H., and Scheuer, P. J.
(1984)
Br. J. Exp. Pathol.
65,
305-311
[Medline]
[Order article via Infotrieve]
-
Tsukamoto, H., Matsuoka, M., and French, S. W.
(1990)
Semin. Liver Dis.
10,
56-65
[Medline]
[Order article via Infotrieve]
-
Zutter, M. M., and Santoro, S. A.
(1990)
Am. J. Pathol.
137,
113-120
[Abstract]
-
Kawada, N., Klein, H., and Decker, K.
(1992)
Biochem. J.
285,
367-371
-
Pinzani, M., Failli, P., Ruocco, C., Casini, A., Milani, S., Baldi, E., Giotti, A., and Gentilini, P.
(1992)
J. Clin. Invest.
90,
642-646
-
Gardner, H., Kreidberg, J., Koteliansky, V., and Jaenisch, R.
(1996)
Dev. Biol.
175,
301-313
[CrossRef][Medline]
[Order article via Infotrieve]
-
Couvelard, A., Scoazec, J.-Y., and Feldmann, G.
(1993)
Am. J. Pathol.
143,
738-752
[Abstract]
-
Volpes, R., van den Oord, J. J., and Desmet, V. J.
(1993)
Am. J. Pathol.
142,
1483-1492
[Abstract]
-
Carloni, V., Romanelli, R. G., Pinzani, M., Laffi, G., and Gentilini, P.
(1996)
Gastroenterology
110,
1127-1136
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ingham, K. C., Brew, S. A., and Migliorini, M. M.
(1989)
J. Biol. Chem.
264,
16977-16980
[Abstract/Free Full Text]
-
Owens, R. J., and Baralle, F. E.
(1986)
EMBO J.
5,
2825-2830
[Medline]
[Order article via Infotrieve]
-
Belkin, V. M., Belkin, A. M., and Koteliansky, V. E.
(1990)
J. Cell Biol.
111,
2159-2167
[Abstract/Free Full Text]
-
Glukhova, M., Koteliansky, V., Fondacci, C., Marotte, F., and Rappaport, L.
(1993)
Dev. Biol.
157,
437-447
[CrossRef][Medline]
[Order article via Infotrieve]
-
Housset, C., Rockey, D. C., and Bissell, D. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
9266-9270
[Abstract/Free Full Text]
-
Pinzani, M., Milani, S., Franco, R. D., Grappone, C., Caligiuri, A., Gentilini, A., Toshi-Guerra, C., Maggi, M., Failli, P., Ruocco, C., and Gentilini, P.
(1996)
Gastroenterology
110,
534-548
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhang, J. X., Pegoli, W. J., and Clemens, M. G.
(1994)
Am. J. Physiol.
266,
G624-G632
[Abstract/Free Full Text]
-
Rockey, D. C., and Weisiger, R. A.
(1996)
Hepatology
24,
233-240
[CrossRef][Medline]
[Order article via Infotrieve]
Volume 272, Number 49,
Issue of December 5, 1997
pp. 30911-30917
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. L. Friedman
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Physiol Rev,
January 1, 2008;
88(1):
125 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Qi, L. Chi, J. Faber, B. Koller, and A. J. Banes
ATP reduces gel compaction in osteoblast-populated collagen gels
J Appl Physiol,
March 1, 2007;
102(3):
1152 - 1160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, C.-C. Chan, O.-S. Kwon, S. Liu, J. McGhee, S. A. Stimpson, L. Z. Chen, W. W. Harrington, W. T. Symonds, and D. C. Rockey
Regulation of peroxisome proliferator-activated receptor-{gamma} in liver fibrosis
Am J Physiol Gastrointest Liver Physiol,
November 1, 2006;
291(5):
G902 - G911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Uyama, L Zhao, E Van Rossen, Y Hirako, H Reynaert, D H Adams, Z Xue, Z Li, R Robson, M Pekny, et al.
Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions
Gut,
September 1, 2006;
55(9):
1276 - 1289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. V Yannas
Similarities and differences between induced organ regeneration in adults and early foetal regeneration
J R Soc Interface,
December 22, 2005;
2(5):
403 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Ng, B. Hinz, and M. A. Swartz
Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro
J. Cell Sci.,
October 15, 2005;
118(20):
4731 - 4739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.E. van Beurden, J.W. Von den Hoff, R. Torensma, J.C. Maltha, and A.M. Kuijpers-Jagtman
Myofibroblasts in Palatal Wound Healing: Prospects for the Reduction of Wound Contraction after Cleft Palate Repair
Journal of Dental Research,
October 1, 2005;
84(10):
871 - 880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kikuchi, C. T. Griffin, S.-S. Wang, and D. M. Bissell
Role of CD44 in Epithelial Wound Repair: MIGRATION OF RAT HEPATIC STELLATE CELLS UTILIZES HYALURONIC ACID AND CD44v6
J. Biol. Chem.,
April 15, 2005;
280(15):
15398 - 15404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jokinen, E. Dadu, P. Nykvist, J. Kapyla, D. J. White, J. Ivaska, P. Vehvilainen, H. Reunanen, H. Larjava, L. Hakkinen, et al.
Integrin-mediated Cell Adhesion to Type I Collagen Fibrils
J. Biol. Chem.,
July 23, 2004;
279(30):
31956 - 31963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Whiting, J. F. Tarlton, M. Bailey, C. L. Morgan, and P. W. Bland
Abnormal Mucosal Extracellular Matrix Deposition Is Associated with Increased TGF-{beta} Receptor-expressing Mesenchymal Cells in a Mouse Model of Colitis
J. Histochem. Cytochem.,
September 1, 2003;
51(9):
1177 - 1189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guidry, K. M. Bradley, and J. L. King
Tractional Force Generation by Human Muller Cells: Growth Factor Responsiveness and Integrin Receptor Involvement
Invest. Ophthalmol. Vis. Sci.,
March 1, 2003;
44(3):
1355 - 1363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yu, L. G. Que, and D. C. Rockey
Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver
Am J Physiol Gastrointest Liver Physiol,
March 1, 2002;
282(3):
G565 - G572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vossmeyer, W. Hofmann, K. Loster, W. Reutter, and K. Danker
Phospholipase Cgamma Binds alpha 1beta 1 Integrin and Modulates alpha 1beta 1 Integrin-specific Adhesion
J. Biol. Chem.,
February 8, 2002;
277(7):
4636 - 4643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hinz, G. Celetta, J. J. Tomasek, G. Gabbiani, and C. Chaponnier
Alpha-Smooth Muscle Actin Expression Upregulates Fibroblast Contractile Activity
Mol. Biol. Cell,
September 1, 2001;
12(9):
2730 - 2741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Abe, S. C. Donnelly, T. Peng, R. Bucala, and C. N. Metz
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
J. Immunol.,
June 15, 2001;
166(12):
7556 - 7562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ramos, M. Montaño, J. García-Alvarez, V. Ruiz, B. D. Uhal, M. Selman, and A. Pardo
Fibroblasts from Idiopathic Pulmonary Fibrosis and Normal Lungs Differ in Growth Rate, Apoptosis, and Tissue Inhibitor of Metalloproteinases Expression
Am. J. Respir. Cell Mol. Biol.,
May 1, 2001;
24(5):
591 - 598.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Varani, D. Spearman, P. Perone, S. E. G. Fligiel, S. C. Datta, Z. Q. Wang, Y. Shao, S. Kang, G. J. Fisher, and J. J. Voorhees
Inhibition of Type I Procollagen Synthesis by Damaged Collagen in Photoaged Skin and by Collagenase-Degraded Collagen in Vitro
Am. J. Pathol.,
March 1, 2001;
158(3):
931 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Nykvist, H. Tu, J. Ivaska, J. Kapyla, T. Pihlajaniemi, and J. Heino
Distinct Recognition of Collagen Subtypes by alpha 1beta 1 and alpha 2beta 1 Integrins. alpha 1beta 1 MEDIATES CELL ADHESION TO TYPE XIII COLLAGEN
J. Biol. Chem.,
March 10, 2000;
275(11):
8255 - 8261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. George, S.-S. Wang, A.-M. Sevcsik, M. Sanicola, R. L. Cate, V. E. Koteliansky, and D. M. Bissell
Transforming Growth Factor-{beta} Initiates Wound Repair in Rat Liver through Induction of the EIIIA-Fibronectin Splice Isoform
Am. J. Pathol.,
January 1, 2000;
156(1):
115 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. George, D. Roulot, V. E. Koteliansky, and D. M. Bissell
In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
PNAS,
October 26, 1999;
96(22):
12719 - 12724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ivaska, H. Reunanen, J. Westermarck, L. Koivisto, V.-M. Kahari, and J. Heino
Integrin {alpha}2{beta}1 Mediates Isoform-specific Activation of p38 and Upregulation of Collagen Gene Transcription by a Mechanism Involving the {alpha}2 Cytoplasmic Tail
J. Cell Biol.,
October 18, 1999;
147(2):
401 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Podolsky
V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense
Am J Physiol Gastrointest Liver Physiol,
September 1, 1999;
277(3):
G495 - G499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Zutter, S. A. Santoro, J. E. Wu, T. Wakatsuki, S. K. Dickeson, and E. L. Elson
Collagen Receptor Control of Epithelial Morphogenesis and Cell Cycle Progression
Am. J. Pathol.,
September 1, 1999;
155(3):
927 - 940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Powell, R. C. Mifflin, J. D. Valentich, S. E. Crowe, J. I. Saada, and A. B. West
Myofibroblasts. I. Paracrine cells important in health and disease
Am J Physiol Cell Physiol,
July 1, 1999;
277(1):
C1 - C19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Klekotka, S. A. Santoro, and M. M. Zutter
alpha 2 Integrin Subunit Cytoplasmic Domain-dependent Cellular Migration Requires p38 MAPK
J. Biol. Chem.,
March 16, 2001;
276(12):
9503 - 9511.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|